FARAPULSE Inc. is a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator and catheters – is intended to ablate heart tissue via the creation of a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation. The FARAPULSE PFA System is an investigational device and not available for sale.
IGEA studies the clinical application of physical stimuli to biological systems. Our mission is to improve patients’ quality of life by developing and producing innovative, effective and safe therapeutic systems for clinical practice. IGEA is the world leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and electrical pulses (electroporation) applied directly to the cancer cells using specific multiple or individual electrodes. Cliniporator® and Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.
Diversified Technologies, Inc. (DTI), a privately held company headquartered in Bedford, Massachusetts, USA, is the developer, manufacturer, and marketer of the PowerMod™ line of solid-state power supplies, pulse modulators, power converters and related high voltage, high power equipment. Founded in 1987, DTI develops advanced technologies through a wide range of commercial and government contracts. DTI’s high voltage systems are used for defense and industrial applications including radar, power conversion, food sterilization, biomass oil extraction, and high-energy physics.
With over 175 installed systems worldwide, Elea is the leading supplier of Pulsed Electric Field (PEF) systems to the food, beverage, and scientific sectors. PEF is an energy-efficient method to open cells of fresh fruit, vegetables, or other raw materials such as meat. This has the effect of extending shelf life or making more efficient use of the raw material for a better final product. The largest machines in the Elea PEF Advantage system range can process up to 60 tonnes of solids or 6000 litres of liquid per hour.
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients. If cleared, the CellFX System will be the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation (NPS) technology to treat a variety of applications for which an optimal solution remains unfulfilled.